Hi my1969z, in your first post a few days ago you said: "Also...

Hi my1969z, in your first post a few days ago you said:

"Also kind of looking like Anisina will be a go, before Cantrixil. Dr. Stein said in her presentation, Anisina dosen't effect the heart, "cardiovascular". Most likely, Ninja Chook(?), is right about this Cantrixil "issue", is actually it potentially having a positive effect on yet another disease."

You must have a good memory!

I have been wondering if the toxicology issue that Ross mentioned in his update is an indication that IP administered Cantrixil is having an effect on organs outside the peritoneal cavity and if this also indicates that IP administered Cantrixil will also have an effect on disease outside of the peritoneal cavity. However, I don't know how they are conducting the toxicology trials, ie how they are administering the drug in the trials (iv/ip/oral) and at what dosages these effects were seen at, so I have a degree of cautious optimism.

Cheers,

Ninja_Chook